Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
City of Hope Medical Center
City of Hope Medical Center
BeOne Medicines
AstraZeneca
City of Hope Medical Center
BeOne Medicines
AVM Biotechnology Inc
New York Medical College
AstraZeneca
Vironexis Biotherapeutics Inc.
AstraZeneca
M.D. Anderson Cancer Center
Galapagos NV
University of Chicago
Medical College of Wisconsin
BeOne Medicines
City of Hope Medical Center
OHSU Knight Cancer Institute
Eli Lilly and Company
University of Michigan Rogel Cancer Center
Dana-Farber Cancer Institute
Fred Hutchinson Cancer Center
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
M.D. Anderson Cancer Center
Acerta Pharma BV
BeOne Medicines
CRISPR Therapeutics
University of Miami
Ohio State University Comprehensive Cancer Center
Barbara Ann Karmanos Cancer Institute
BeiGene
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Cancer Research UK
Nantes University Hospital
Mayo Clinic
M.D. Anderson Cancer Center
City of Hope Medical Center
AIDS Malignancy Consortium
Aprea Therapeutics
Oncternal Therapeutics, Inc
Cyteir Therapeutics, Inc.
Oncternal Therapeutics, Inc
Icahn School of Medicine at Mount Sinai
Genmab
Stanford University
Columbia University
Columbia University
University Hospital Heidelberg
IGM Biosciences, Inc.
MingSight Pharmaceuticals, Inc
Fred Hutchinson Cancer Center